Interim guidelines on the management and administration of Tozinameran COVID-19 mRNA vaccine (nucleoside-modified) [Cominarty] Pfizer COVID-19 vaccine to pediatric population ages 5-11 years old

Department Memorandum 2022-0041: Interim guidelines on the management and administration of Tozinameran COVID-19 mRNA vaccine (nucleoside-modified) [Cominarty] Pfizer COVID-19 vaccine to pediatric population ages 5-11 years old

Category: 

2019-nCoV Interim Guidelines

2019 nCoV Update

Date: 

Monday, January 24, 2022

Document Type: 

Department Memorandum 2022-0041

File: 

dm2022-0041.pdf